- Worldwide over two billion pigs have been protected against Porcine Circovirus Disease using Ingelvac CircoFLEX®
- The vaccine contributes to sustainable production and supply of healthy, nutritious pork around the world like no other vaccine1
Ingelheim, Germany, 26 October 2016 – Veterinarians and pig farmers were able to protect over two billion pigs around the world against Porcine Circovirus Disease using Ingelvac CircoFLEX®, the most successful animal health vaccine of all time based on yearly sales2. With more than eight pigs vaccinated every second worldwide, the vaccine contributes to sustainable production and supply of healthy, nutritious pork around the world like no other vaccine.1
“We are very proud of this milestone, and we know that it has been finally achieved by our customers – veterinarians and pig farmers around the world doing their best to prevent disease. We would like to thank them for the trust and loyalty they put into Ingelvac CircoFLEX®”, said George Heidgerken, Head of Boehringer Ingelheim Animal Health. “We continue to strive to provide the best protection against Porcine Circovirus to the global pig industry by an integrated solutions approach. This includes the supply of a high quality vaccine and tailored customer services.”
Porcine Circovirus Disease can have a devastating impact on the pigs’ health, causing suffering to the animals and economic damage to farmers. An infection with the Porcine Circovirus Type 2 (PCV 2) in unprotected pigs may lead to wasting, paleness of the skin, respiratory dysfunction (dyspnea) or diarrhoea in piglets. PCV2 can also cause medically and economically relevant subclinical infections (infections without evident clinical signs).
Ingelvac CircoFLEX® provides proven protection without compromising safety with just one shot around weaning. It is licensed to be freshly mixed with Ingelvac MycoFLEX® to protect pigs with one shot against both, PCV 2 and Mycoplasma hyopneumoniae which causes respiratory disease in pigs. Ingelvac CircoFLEX® has been recently approved to be used in sows by the European Medicines Agency.
1) Based on Doses Sold, August 2016, Data on file
2) Based on net sales, MAT Q2 2016, Data on file